Well, I like the pps prior to the Sundry acquisition. Feel like putting in a sell limit order at my b/e, $4.82, and never look back.
Some pharma co. comes out and says they had positive results on one patient in a Phase one trial, and the stock shoots up 200%. Another says they enrolled one patient for a clinical trial to begin in 2025 and it rockets.
Real news here and goes down, steaming towards 52-week low.
Nothing makes sense anymore. But I guess we see the power of programmable trading by hedge funds and big banks with algorithms.